Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
XRTXthis companyXORTX Therapeutics Inc.	$0.98	-1×	1.28×	0×	-0.58×	-60.6%	0.0%	0.0%	0.0%	-127.7%	-153.7%	-105.9%	0.02×	0.26×	0×	1.61×	0.0%	1	-5.45	2	C+
LEXXLexaria Bioscience Corp.	$4.59	-1.33×	5.3×	22.44×	-1.2×	-797.4%	99.6%	-1683.0%	-1686.0%	-398.1%	-438.1%	-66.1%	0.04×	0.14×	0×	2.32×	0.0%	2	-16.17	2	C
Peer median	—	-1.33×	5.3×	22.44×	-1.2×	-797.4%	99.6%	-1683.0%	-1686.0%	-398.1%	-438.1%	-66.1%	0.04×	0.14×	0×	2.32×	0.0%	2	-16.17	2	—